Your implants are ageing. Right now. In the drawer.
Every Implant Has a Birthday
The day it was manufactured, sterilised, and sealed in packaging. From that moment, a biological clock starts ticking.
And here’s what nobody tells you: this clock measures the progressive degradation of surface bioactivity—hydrocarbon contamination from just sitting in the atmosphere. So, by the time an implant reaches your surgical tray, weeks or months after manufacture, it’s no longer biologically fresh.
The phenomenon is called biological ageing, and understanding it fundamentally changes how you think about implant success and failure.
More importantly, there’s a protocol that reverses it: photofunctionalisation.
Let me show you the mechanism, the evidence, and the clinical protocol that can transform outcomes in your practice.
What They Don’t Teach You
Traditional implant education focuses on what you control: surgical technique, bone quality assessment, primary stability, loading protocols, and prosthetic design.
These matter. (Obviously.) But they don’t tell the whole story.
What conventional training overlooks—and I mean completely overlooks—is that the implant itself is a biological variable. The surface that contacts bone isn’t static. It changes over time, and not for the better.
Most courses teach surface roughness as if it’s the only thing that matters. You learn about SLA, anodisation, and micro-topography for osteoblast attachment—all important stuff.
What you don’t learn is that these carefully engineered surfaces start degrading the moment they’re exposed to air.
I spent years placing implants before I understood this, genuinely wondering why some cases in “good bone” struggled, why identical techniques produced different outcomes.
I’d review everything: Did we achieve adequate primary stability? Was healing sufficient? Could there have been contamination?
All reasonable questions. All missing the point.
Because the root cause predated the surgery entirely: The implant was already compromised before I opened the package.
The Biology They Should Have Taught You
Titanium isn’t biologically inert. The oxide layer that forms on titanium surfaces, the layer responsible for biocompatibility, actively interacts with its environment.
In sterile manufacturing conditions, this surface has high surface energy and excellent hydrophilicity, perfect for blood contact, protein adsorption, and cell attachment.
Once it’s exposed to air, hydrocarbons start depositing on the surface. You can’t see it, can’t smell it, but it’s happening.
Within four weeks of manufacture, the surface properties have measurably degraded. Four weeks. That’s it.
The Ogawa Research (Or: The Data That Should Change Everything)
The research quantifying this comes primarily from Takahiro Ogawa and colleagues at UCLA. Their work demonstrated that aged titanium surfaces show:
Reduced surface energy
Increased water contact angle (loss of hydrophilicity)
Reduced osteoblast attachment by approximately 50%
Compromised bone-to-implant contact potential
The biological consequence? Significant doesn’t even cover it.
Fresh surfaces achieve BIC values that aged surfaces simply cannot match. In controlled studies, aged surfaces achieved approximately 55% BIC while photofunctionalised surfaces achieved 98.2% BIC.
Read that again. 55% versus 98.2%.
This isn’t a marginal difference—this is a fundamentally different biological response. Same implant design, same surgical technique, completely different biology.
Why This Happens
The mechanism is straightforward once you understand it. Hydrocarbons on the surface interfere with the initial protein adsorption cascade that precedes cell attachment. When blood contacts a contaminated surface, the biological signalling that recruits osteoblasts gets compromised.
The implant still integrates. Sure. But not optimally.
The surface that could have achieved near-complete bone contact settles for partial integration, and you never know what you’ve left on the table.
This explains those clinical observations that used to drive me mad: Why do some implants perform better than others in identical conditions? Why does the same surgeon see different healing patterns with the same implant system? Why do some cases in “favourable” conditions still struggle?
Surface age is one variable among many, but it’s been systematically overlooked. And that needs to change.
Clinical Implications: When Surface Conditioning Actually Matters
Understanding biological ageing reframes how you make clinical decisions. Instead of treating all implants as equivalent (which they’re not), you can stratify risk based on what you actually know.
Strong Indications for Photofunctionalisation
Compromised host situations where optimal integration is critical:
You know the patients I’m talking about: diabetic patients with HbA1c at the upper acceptable limit, history of smoking (recently quit), older patients with reduced bone density.
Any systemic factor that narrows the margin between success and failure. In these cases, every biological advantage matters.
Immediate loading protocols where rapid stability is required:
Here’s what the research shows: the characteristic ISQ dip at three weeks—that period when primary mechanical stability transitions to secondary biological stability—gets eliminated with photofunctionalised surfaces.
This means loading timelines can potentially be compressed in appropriate cases.
Immediate loading criteria expand, and the margin of safety in challenging cases increases.
Cases with marginal primary stability where you need every advantage:
Type IV bone, compromised extraction sockets, and situations where the mechanical foundation is less than ideal. You’re already on the edge—why wouldn’t you optimise the biology?
Moderate Indications
Implants stored longer than four weeks:
If you’re unsure how long an implant has been sitting in your inventory (and let’s be honest, who actually tracks this?), surface conditioning provides insurance.
Final abutment placement:
Soft tissue integration benefits from surface conditioning with argon plasma. Research from Canullo and colleagues has demonstrated benefits particularly for abutment surfaces.
The Evidence on Outcomes
Funato and colleagues demonstrated that photofunctionalised implants reach a stability plateau in 2 months compared to 4 months for untreated surfaces. The characteristic stability dip at three weeks? Gone.
So, immediate loading criteria expand, the margin of safety in challenging cases increases, and loading timelines compress in appropriate cases. All from treating the surface properly.
Important caveat—and I mean this:
Photofunctionalisation does not replace sound surgical principles. It enhances the biological response to surgery that’s already performed correctly. You can’t rescue poor surgical technique with surface treatment. Don’t even try.
The Protocol Framework
How Photofunctionalisation Works
You expose the implant surface to UV-C light at 254nm wavelength. This specific wavelength has sufficient energy to break the carbon-carbon and carbon-hydrogen bonds in hydrocarbon contaminants. The treatment removes the contamination layer and restores superhydrophilicity.
Treatment duration: Varies by device. 12–48 minutes for old school devices. Modern devices take just 60 secs. (Yes, that quick!)
Critical timing: Treatment must be performed immediately before placement. The refreshed surface will begin accumulating contaminants upon atmospheric exposure.
Clinical Decision Gates
Here’s where most courses hedge: “It depends.” Yeah. I’m not doing that.
STRONG RECOMMENDATION:
Compromised host situations
Immediate loading protocols
MODERATE RECOMMENDATION:
Implants stored > 4 weeks
Cases with low primary stability
Final abutment placement (consider argon plasma or UV-C)
Clear enough?
Practical Implementation
The workflow integration is about as straightforward as it gets.
Place the UV-C device in your surgical suite. While you’re preparing the surgical site, the implant is being treated. By the time your osteotomy is complete, the implant is ready with a freshly activated surface.
The workflow adds minimal time. The biological advantage is potentially significant. Worth it? Absolutely.
Alternative: Argon Plasma Treatment
Similar mechanism—removing organic contamination. Research from Canullo and colleagues has demonstrated benefits particularly for abutment surfaces where soft tissue integration is the priority. Another tool in the arsenal.
The Question You Need to Answer
Biological ageing is not theoretical. It’s documented, measurable, clinical, and real.
The evidence base supports surface conditioning as a method to optimise outcomes, particularly in cases where the margin for error is narrow.
The question isn’t whether your implants age. They do. Right now. In your drawer.
The question is whether you’ll continue treating all surfaces as equivalent, or whether you’ll integrate this knowledge into your clinical decision-making.
Can you skip photofunctionalisation? Sure. The 90% of straightforward cases will probably be fine.
But here’s the thing:
If you’re reading this, you’re not interested in “probably fine.” You’re interested in understanding the invisible 10%—the biological variables that separate predictable integration from cases that struggle. You want to stack every biological advantage in your patient’s favour when the margin between success and failure narrows.
That’s the difference between competence and mastery.
At the Academy, we teach the biology behind the protocols. Understanding biological ageing is one example of the depth that changes practice. Not because it’s complicated, but because most clinicians never learned it.
And once you understand it, you can’t unknow it. Excellence stops being optional.
Ready to Understand the Biology Behind the Protocols?
The Academy of Implant Excellence teaches system-agnostic, biology-first implant training. From single implants to full-arch mastery. 80+ hours of depth that covers the invisible 10% where complications happen.
Because protocols work until they don’t.
References
- Att W, Ogawa T. Biological aging of implant surfaces and their restoration with ultraviolet light treatment: a novel understanding of osseointegration. Int J Oral Maxillofac Implants. 2012;27(4):753-761.
- Aita H, Hori N, Takeuchi M, et al. The effect of ultraviolet functionalization of titanium on integration with bone. Biomaterials. 2009;30(6):1015-1025.
- Funato A, Yamada M, Ogawa T. Success rate, healing time, and implant stability of photofunctionalized dental implants. Int J Oral Maxillofac Implants. 2013;28(5):1261-1271.
- Ogawa T. Ultraviolet photofunctionalization of titanium implants. Int J Oral Maxillofac Implants. 2014;29(1):e95-e102.
- Canullo L, Tallarico M, Unique A, et al. Plasma of argon treatment of the implant surface for soft tissue integration: a pilot study. Clin Implant Dent Relat Res. 2023;25(1):117-125.
- Elkhidir Y, Cheng Y. Photofunctionalization of titanium implants: an alternative approach. J Dent. 2017;61:54-59.
- Suzuki T, Hori N, Oharai Y, et al. Ultraviolet treatment overcomes time-related degrading bioactivity of titanium. Tissue Eng Part A. 2009;15(12):3679-3688.